NeoClone produces high-quality monoclonal antibody products for the biotechnology and research markets. NeoClone holds exclusive license to the ABL-MYC retroviral transformation system, a technique that produces monoclonal antibodies -- "NeoClone®"-brand or "NeoAb®" antibodies -- in an...
Your Rating
You must submit at least one review.
Review successfully posted.
You will shortly receive an email to confirm your review.
Currently no review was submitted for this company. Share your experiences with this company!